Home Cart 0 Sign in  

[ CAS No. 25939-81-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 25939-81-5
Chemical Structure| 25939-81-5
Structure of 25939-81-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 25939-81-5 ]

Related Doc. of [ 25939-81-5 ]

Alternatived Products of [ 25939-81-5 ]

Product Details of [ 25939-81-5 ]

CAS No. :25939-81-5 MDL No. :MFCD00956664
Formula : C11H15N Boiling Point : -
Linear Structure Formula :- InChI Key :UDWVZWUSBKDYPY-UHFFFAOYSA-N
M.W : 161.24 Pubchem ID :3798338
Synonyms :

Calculated chemistry of [ 25939-81-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.45
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 55.4
TPSA : 12.03 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.69 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.37
Log Po/w (XLOGP3) : 2.25
Log Po/w (WLOGP) : 1.58
Log Po/w (MLOGP) : 2.39
Log Po/w (SILICOS-IT) : 2.83
Consensus Log Po/w : 2.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.56
Solubility : 0.443 mg/ml ; 0.00275 mol/l
Class : Soluble
Log S (Ali) : -2.14
Solubility : 1.17 mg/ml ; 0.00727 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.83
Solubility : 0.0239 mg/ml ; 0.000148 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.01

Safety of [ 25939-81-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 25939-81-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 25939-81-5 ]
  • Downstream synthetic route of [ 25939-81-5 ]

[ 25939-81-5 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 1582284-65-8 ]
  • [ 25939-81-5 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 16, p. 3982 - 3985
  • 2
  • [ 24423-87-8 ]
  • [ 557-20-0 ]
  • [ 777061-38-8 ]
  • [ 25939-81-5 ]
Reference: [1] Organic Letters, 2010, vol. 12, # 12, p. 2690 - 2693
  • 3
  • [ 24423-87-8 ]
  • [ 557-20-0 ]
  • [ 365564-07-4 ]
  • [ 25939-81-5 ]
  • [ 1229227-19-3 ]
Reference: [1] Organic Letters, 2010, vol. 12, # 12, p. 2690 - 2693
  • 4
  • [ 24423-87-8 ]
  • [ 480438-75-3 ]
  • [ 557-20-0 ]
  • [ 25939-81-5 ]
  • [ 1229227-17-1 ]
Reference: [1] Organic Letters, 2010, vol. 12, # 12, p. 2690 - 2693
  • 5
  • [ 886759-39-3 ]
  • [ 25939-81-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2006, vol. 41, # 2, p. 241 - 252
[2] European Journal of Medicinal Chemistry, 2009, vol. 44, # 10, p. 4034 - 4043
  • 6
  • [ 41173-70-0 ]
  • [ 25939-81-5 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 666
[2] Chemical Science, 2017, vol. 8, # 5, p. 4093 - 4099
  • 7
  • [ 6283-04-1 ]
  • [ 25939-81-5 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 666
  • 8
  • [ 79-03-8 ]
  • [ 64-04-0 ]
  • [ 25939-81-5 ]
  • [ 4965-09-7 ]
Reference: [1] Patent: US5686458, 1997, A,
  • 9
  • [ 886759-13-3 ]
  • [ 25939-81-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2006, vol. 41, # 2, p. 241 - 252
  • 10
  • [ 886759-19-9 ]
  • [ 25939-81-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2006, vol. 41, # 2, p. 241 - 252
  • 11
  • [ 886759-31-5 ]
  • [ 25939-81-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2006, vol. 41, # 2, p. 241 - 252
  • 12
  • [ 886759-25-7 ]
  • [ 25939-81-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2006, vol. 41, # 2, p. 241 - 252
  • 13
  • [ 3230-65-7 ]
  • [ 925-90-6 ]
  • [ 25939-81-5 ]
Reference: [1] Chemische Berichte, 1958, vol. 91, p. 1133,1138
[2] Heterocycles, 1982, vol. 19, # 4, p. 653 - 656
  • 14
  • [ 91-21-4 ]
  • [ 25939-81-5 ]
Reference: [1] Heterocycles, 1982, vol. 19, # 4, p. 653 - 656
  • 15
  • [ 493-05-0 ]
  • [ 25939-81-5 ]
Reference: [1] Chemische Berichte, 1958, vol. 91, p. 1133,1138
[2] Chemische Berichte, 1958, vol. 91, p. 1133,1138
  • 16
  • [ 60355-20-6 ]
  • [ 25939-81-5 ]
Reference: [1] Chemische Berichte, 1958, vol. 91, p. 1133,1138
  • 17
  • [ 22901-09-3 ]
  • [ 25939-81-5 ]
Reference: [1] Chemische Berichte, 1958, vol. 91, p. 1133,1138
  • 18
  • [ 91-21-4 ]
  • [ 75-03-6 ]
  • [ 25939-81-5 ]
Reference: [1] Tetrahedron, 1986, vol. 42, # 9, p. 2571 - 2574
Same Skeleton Products
Historical Records

Similar Product of
[ 25939-81-5 ]

Chemical Structure| 103861-49-0

A578357[ 103861-49-0 ]

1-Ethyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

Reason: Free-salt

Related Parent Nucleus of
[ 25939-81-5 ]

Tetrahydroisoquinolines

Chemical Structure| 180272-45-1

[ 180272-45-1 ]

(1R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline

Similarity: 0.97

Chemical Structure| 22990-19-8

[ 22990-19-8 ]

1-Phenyl-1,2,3,4-tetrahydroisoquinoline

Similarity: 0.97

Chemical Structure| 4965-09-7

[ 4965-09-7 ]

1-Methyl-1,2,3,4-tetrahydroisoquinoline

Similarity: 0.97

Chemical Structure| 29726-60-1

[ 29726-60-1 ]

3-Methyl-1,2,3,4-tetrahydroisoquinoline

Similarity: 0.97

Chemical Structure| 118864-75-8

[ 118864-75-8 ]

(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline

Similarity: 0.92